Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2327 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Adaltis Q4 net loss narrows to C$14.56m

Adaltis, an in vitro diagnostic company, has reported a net loss of C$14.56m, or C$0.12 per share, for the fourth quarter of 2008, compared to a net loss

Endo Pharmaceuticals names new board member

Dr Hutson retired from Pfizer in 2006 after spending 25 years in various research and leadership positions with that company, serving most recently as senior vice president of